Brief: Contrafect reports Q2 results
Aug 15 (Reuters) - ContraFect Corp CFRX.O :
* CONTRAFECT REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.46
* AS OF JUNE 30, 2022, CONTRAFECT HAD CASH, CASH EQUIVALENTS
AND
MARKETABLE SECURITIES OF $27.3 MILLION
* Q2 EARNINGS PER SHARE VIEW $-0.37 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7d2PGR
Further company coverage: CFRX.O
Recent news on CONTRAFECT
See all newsBrief: Contrafect Corp - On Nov 7, Co Received Delisting Notification From Nasdaq Hearings Advisor Stating That Panel Determined To Delist Co's Common Stock
Brief: ContraFect Says Selling Securityholder May Offer And Selling Up To 7 Mln Shares In Aggregate Of Common Stock
Brief: Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study
Brief: Contrafect Corp Says On Sept 21, Notified By Nasdaq, That Co Not In Compliance With The Minimum Bid Price Requirement
Brief: Contrafect Announces Submission Of Ind Application To The FDA For Its Development Candidate Cf-370